4′-Fluorouridine works against RNA-dependent RNA polymerase, an enzyme that helps viruses assemble RNA. The compound has a ...

Theratechnologies gains exclusive rights to two investigational RNA-targeted medicines from Ionis Pharmaceuticals, olezarsen ...

Get the last 2 weeks biotech industry news in this quick roundup of the last fortnight's products, people and partnerships ...

Dominique Verhelle is co-founder and CEO of the Brighton-based company NextRNA Therapeutics, which uses long non-coding RNA ...

Massachusetts, USA-based clinical stage biotech Rgenta Therapeutics, which is developing a new class of oral small molecules ...

The heart has long been thought to be controlled solely by the autonomic nervous system, which transmits signals from the ...

For decades, scientists believed the heart was a normal organ controlled entirely by the brain. Now, the picture just got a ...

Choosing a film for a movie night is always a battle. Now imagine if you could pick one that provided a window into some of ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

Theratechnologies (THTX) has entered into an agreement with Ionis Pharmaceuticals to license two investigational RNA-targeted ...

Theratechnologies (TSE:TH) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...